FIP Antiviral GS-441524 40mg Tablets Feline Oral Vet Supply Korea Japan EU

Product Overview

GS-441524 40mg scored oral tablets for the veterinary treatment of Feline Infectious Peritonitis (FIP). Each box contains 10 tablets in a sealed blister pack with detailed weight-based dosing instructions. GS-441524 is a nucleoside analog antiviral that targets viral RNA replication, providing an effective oral treatment option for FIP in cats.

The 40mg strength is designed for kittens, small-breed cats, and the initial dose-titration phase of FIP treatment where precise weight-adjusted dosing is critical. The scored tablet can be halved to 20mg for cats under 2kg. Manufactured under GMP conditions with HPLC purity verification and COA provided per batch.

Key Features & Advantages

• 40mg Precision Dosing: Ideal for cats under 3kg and kittens diagnosed with FIP, where lower-dose accuracy improves safety margins during the 12-week treatment protocol.
• Scored Tablet for Flexible Dosing: Cleanly splits to 20mg half-doses for very small cats, giving veterinarians precise control over daily mg/kg administration.
• Room Temperature Stable: No cold-chain required. Simplifies import, storage, and dispensing across European and Asian veterinary supply chains.
• GMP Batch Traceability: Each production batch tested for HPLC purity, dissolution, content uniformity, and microbial limits. Full COA documentation included.

Target Markets

• South Korea & Japan: High demand for low-dose GS-441524 tablets for kitten FIP cases. Korean and Japanese-language product documentation available.
• Poland, Sweden & EU: Distributed through licensed veterinary pharmaceutical importers across EU member states. Multilingual packaging and COA for regulatory compliance.

Packaging & Documentation

Each box contains 10 individually blistered tablets. Package insert provides dosing tables in English, Korean, Japanese, Polish, and Swedish. Lot number and expiration date printed on blister and outer box.